A phase II double-blind, randomised controlled trial of VEGF inhibitor axitinib monotherapy with early dynamic contrast-enhanced ultrasound monitoring in chemo-refractory third-line metastatic colorec...

Update Il y a 4 ans
Reference: ISRCTN70833965

A phase II double-blind, randomised controlled trial of VEGF inhibitor axitinib monotherapy with early dynamic contrast-enhanced ultrasound monitoring in chemo-refractory third-line metastatic colorectal cancer

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

http://www.cancerresearchuk.org/cancer-help/trials/a-trial-looking-axitinib-advanced-bowel-cancer-axmus-c


Inclusion criteria

  • Topic: National Cancer Research Network; Subtopic: Colorectal Cancer; Disease: Colon, Rectum

Links